These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 11593564
1. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes. Wang Y, Zhang J, Gao Y, Yu M, Gong Y, Yu G. Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564 [Abstract] [Full Text] [Related]
2. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, Iwai S. Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183 [Abstract] [Full Text] [Related]
3. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, Maeda N, Tomoda K, Nakamura H. Cardiovasc Intervent Radiol; 2008 Feb; 31(6):1108-16. PubMed ID: 18543028 [Abstract] [Full Text] [Related]
4. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow-up. Nakao N, Kamino K, Miura K, Takayasu Y, Ohnishi M, Miura T. Radiat Med; 1992 Feb; 10(1):13-8. PubMed ID: 1316626 [Abstract] [Full Text] [Related]
5. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma]. Jin-no K. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695 [Abstract] [Full Text] [Related]
6. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization. Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Ogura T, Hagihara A, Iwasa S. Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589 [Abstract] [Full Text] [Related]
7. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M. Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [Abstract] [Full Text] [Related]
8. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma]. Shi Z, Guo Y, Liu D. Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839 [Abstract] [Full Text] [Related]
9. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee PC, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Chau GY, Chiang JH, Lui WY, Lee SD, Wu JC. Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337 [Abstract] [Full Text] [Related]
10. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma. Lin WY, Wang SJ, Yeh SH. Neoplasma; 1995 Oct; 42(2):89-92. PubMed ID: 7617083 [Abstract] [Full Text] [Related]
11. Management of spontaneous bleeding due to hepatocellular carcinoma. Recordare A, Bonariol L, Caratozzolo E, Callegari F, Bruno G, Di Paola F, Bassi N. Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230 [Abstract] [Full Text] [Related]
12. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D'Angelica M, Blumgart L, DeMatteo R, Brown KT. J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503 [Abstract] [Full Text] [Related]
13. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report]. Hasegawa I, Hirashima N. Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632 [Abstract] [Full Text] [Related]
14. Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments. Arai K, Matsui O, Takashima T, Kadoya M, Yoshikawa J, Gabata T, Ueda K, Kawamori Y, Izumi R, Kobayashi K. Radiat Med; 1990 Feb; 8(5):191-8. PubMed ID: 1963696 [Abstract] [Full Text] [Related]
15. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, Jarnagin W, Dematteo R, Blumgart LH, Fong Y, Brown KT. J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900 [Abstract] [Full Text] [Related]
16. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma]. Takekoshi H, Oyama R. Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966 [Abstract] [Full Text] [Related]
17. [Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization]. Cheng L, Wang Z, Cai F. Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):362-4. PubMed ID: 9387276 [Abstract] [Full Text] [Related]
18. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Liao GS, Yu CY, Shih ML, Chan DC, Liu YC, Yu JC, Chen TW, Hsieh CB. Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711 [Abstract] [Full Text] [Related]
19. Palliative treatment of hepatocellular carcinoma with transcatheter arterial embolization. Savastano S, Feltrin GP, Neri D, da Pian P, Chiesura-Corona M, Roman E, Battaglia G, Gerunda G, Lise M, Miotto D. Acta Radiol; 1993 Jan; 34(1):26-9. PubMed ID: 7678975 [Abstract] [Full Text] [Related]
20. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma. Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S. Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]